Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12126
BiomX
PHGE
$1.92M
| $35K | ﹤0.01% |
18,707
+10,192
| +120% | +$68.6K |
|
|
IMRN
12127
Immuron
IMRN
$9.2M
| $34.9K | ﹤0.01% |
45,782
+26,220
| +134% | +$43.2K |
|
12128
PUT
ProKidney
PROK
$334M
| $34.7K | ﹤0.01% |
15,500
-29,800
| -66% | -$78.4K |
|
12129
Bit Origin
BTOG
$2.2M
| $34.6K | ﹤0.01% |
+3,358
| New | +$62.6K |
|
12130
Lucas GC Ltd
LGCL
$59.1M
| $34.6K | ﹤0.01% |
15,516
+11,663
| +303% | +$35.1K |
|
12131
Wah Fu Education Group
WAFU
$5.91M
| $34.5K | ﹤0.01% |
+22,408
| New | +$38.6K |
|
12132
CALL
Dolphin Entertainment
DLPN
$14.8M
| $34.5K | ﹤0.01% |
+22,100
| New | +$34.8K |
|
|
CURX
12133
Curanex Pharmaceuticals
CURX
$5.79M
| $34.5K | ﹤0.01% |
104,278
+40,211
| +63% | +$22.1K |
|
12134
PUT
Flux Power
FLUX
$12M
| $34.4K | ﹤0.01% |
27,100
+4,100
| +18% | +$12.1K |
|
12135
CALL
BRC Inc
BRCC
$119M
| $34.4K | ﹤0.01% |
31,000
-100
| -0.3% | -$130 |
|
|
SKK
12136
SKK Holdings
SKK
$11.6M
| $34.4K | ﹤0.01% |
12,419
+763
| +7% | +$2.62K |
|
12137
Asia Pacific Wire & Cable
APWC
$64.7M
| $34.3K | ﹤0.01% |
+18,229
| New | +$33.8K |
|
|
AGEN
12138
PUT
Agenus
AGEN
$334M
| $34.2K | ﹤0.01% |
10,900
-25,900
| -70% | -$103K |
|
12139
CALL
Aware
AWRE
$27.7M
| $34.2K | ﹤0.01% |
+18,400
| New | +$41.6K |
|
12140
Creative Medical Technology
CELZ
$4.16M
| $34.2K | ﹤0.01% |
+17,460
| New | +$51.6K |
|
|
BLRX
12141
PUT
BioLineRX
BLRX
$12.1M
| $34.2K | ﹤0.01% |
+12,000
| New | +$41.5K |
|
12142
BioRestorative Therapies
BRTX
$5.53M
| $34.2K | ﹤0.01% |
29,198
-77,012
| -73% | -$103K |
|
|
LGO
12143
CALL
Largo
LGO
$71.8M
| $33.9K | ﹤0.01% |
+36,200
| New | +$43K |
|
12144
CALL
Definitive Healthcare
DH
$71.8M
| $33.9K | ﹤0.01% |
11,800
-500
| -4% | -$1.39K |
|
12145
PUT
BuzzFeed
BZFD
$94.9M
| $33.9K | ﹤0.01% |
36,400
-1,200
| -3% | -$1.52K |
|
12146
Equus Total Return
EQS
$16.2M
| $33.8K | ﹤0.01% |
+23,884
| New | +$44.8K |
|
|
AURE
12147
Aurelion Inc
AURE
$65.5M
| $33.8K | ﹤0.01% |
13,525
+6,837
| +102% | +$35.3K |
|
|
FENG
12148
Phoenix New Media
FENG
$18.3M
| $33.7K | ﹤0.01% |
20,199
+4,205
| +26% | +$9.28K |
|
12149
CALL
TherapeuticsMD
TXMD
$23.6M
| $33.6K | ﹤0.01% |
+20,600
| New | +$29.8K |
|
12150
NeuroOne Medical Technologies
NMTC
$14.1M
| $33.6K | ﹤0.01% |
7,382
-26,998
| -79% | -$123K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.